From the Anagenics divestment of Advangen Japan (only)
• Important intellectual property (patents and certain trademarks) developed under the
ownership of ADV Japan have been reassigned and continue to remain under the full
ownership and control of AN1. The control of key patents and trademarks worldwide
ensures AN1 retains full access to international markets, including China and Japan,
for its évolis® brands and core FGF5 inhibitor technologies.
This does not say " but only in relation to hair loss"
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.481M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1766342 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 332362 | 2 |
View Market Depth
| Last trade - 10.00am 28/07/2025 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable